Decoding the Rise of Tepezza: Horizon Therapeutics’ Game-Changing Approach to Thyroid Eye Disease Treatment
In the realm of pharmaceutical breakthroughs, Horizon Therapeutics stands out as a pioneer in revolutionizing treatment for thyroid eye disease (TED). With the introduction of Tepezza, the first IGF-1R blocker for TED patients, Horizon achieved a significant milestone, reshaping the
Leveraging Medical Analytics for Better Outcomes
The healthcare industry is witnessing a transformative shift fueled by advanced medical analytics. Imagine unlocking insights that redefine strategies, optimize product launches, and ultimately enhance patient outcomes and care models. It’s not just a vision—it’s a reality for forward-thinking Medical
Beyond the Pill: Improving Patient Medication Adherence
Despite advancements in treatment modalities and support services, patient adherence rates often plateau, leaving both patients and healthcare providers grappling with suboptimal outcomes. Shockingly, adherence rates for brands can plummet to as low as 60%. The journey towards optimal adherence
Elevating Standards: Industry Benchmarks on Building Medical Excellence Groups
In today’s rapidly evolving healthcare landscape, Medical Excellence (Med X) groups play a pivotal role in driving transformation within Medical Affairs. These groups are instrumental in both tactical and strategic phases of evolution. During their inception, Med X teams focus
When Personal and Professional Experiences Meet, Our Clients Benefit: Part 4 of New Series
Let’s be real, 2020 has been a hard year. It’s hard to know what to do or what not to do; it’s hard to navigate business decisions, when it’s NOT business as usual. We want you to know that while
When Personal and Professional Experiences Meet, Our Clients Benefit: Part 3 of New Series
Let’s be real, 2020 has been a difficult year thus far. We see people hunkering down, their focus shifting and some reticence to make decisions. Best Practices has felt these seismic shifts as well, but one thing that has not
When Personal and Professional Experiences Meet, Our Clients Benefit: Part 2 of New Series
2020 has been a difficult year, but the need for speed in making business decision is becoming more critical. Best Practices recognizes that seismic shifts in how business is conducted are facing all companies, and we want to re-confirm our
When Personal and Professional Experiences Meet, Our Clients Benefit: Part 1 of New Series
Let’s be real, 2020 has been a hard year for most of us. It’s hard to know what to do or what not to do; it’s hard to navigate business decisions, when it’s NOT business as usual. We see people
How Elite Medical Affairs Teams Help Drive a Successful Pharma Product Launch
A highly regulated marketplace, coupled with intensifying competition, have pushed the Medical Affairs function into a significant launch role that extends from the pre-launch phases to well beyond market entry. Best-in-class Medical Affairs groups can become a kind of conduit
Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?
Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Apple’s announcement for AC Wellness follows on the heels of
Brand Lifecycle Management: Strategies for Every Budget
At every investment level, superior strategies emerge Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels
Evidence-based Tactics Impact TRx Growth
Co-pay and adherence programs continue to be the most effective tactics to drive TRx pull through Many pharmaceutical companies use co-pay cards and adherence programs as individual tactics in their patient support programs, but health care consultancies Best Practices, LLC
Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal
Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this
Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry
When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. For decades, disease awareness campaigns were a part of the playbook for educating physicians and patients about new